NantHealth Inc (NH) Stock Price Down 6.8%
NantHealth Inc (NYSE:NH)’s share price traded down 6.8% during trading on Monday . The stock traded as low as $13.32 and last traded at $13.51, with a volume of 124,475 shares trading hands. The stock had previously closed at $14.50.
Several equities analysts have recently commented on the company. Zacks Investment Research lowered NantHealth from a “hold” rating to a “sell” rating in a research note on Wednesday, September 14th. First Analysis assumed coverage on NantHealth in a research note on Monday, June 27th. They issued an “overweight” rating and a $18.00 price target on the stock. FBR & Co reaffirmed a “buy” rating on shares of NantHealth in a research note on Wednesday, August 10th. Canaccord Genuity assumed coverage on NantHealth in a research note on Monday, June 27th. They issued a “buy” rating and a $17.00 price target on the stock. Finally, Jefferies Group assumed coverage on NantHealth in a research note on Monday, June 27th. They set a “buy” rating on the stock. One equities research analyst has rated the stock with a sell rating and five have given a buy rating to the stock. NantHealth presently has a consensus rating of “Buy” and a consensus target price of $18.00.
The stock’s market cap is $1.65 billion. The stock has a 50-day moving average of $11.69 and a 200-day moving average of $12.47.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/19/nanthealth-inc-nh-stock-price-down-6-8.html
NantHealth (NYSE:NH) last released its quarterly earnings results on Tuesday, August 9th. The company reported ($0.15) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.41) by $0.26. The business earned $31.50 million during the quarter, compared to analyst estimates of $23.55 million. The company’s revenue for the quarter was up 166.9% compared to the same quarter last year. On average, equities research analysts forecast that NantHealth Inc will post ($0.63) earnings per share for the current year.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in NH. Wildcat Capital Management LLC acquired a new position in NantHealth during the second quarter valued at approximately $3,008,000. Jefferies Group LLC purchased a new stake in shares of NantHealth during the second quarter valued at about $6,943,000. Blackstone Group L.P. purchased a new stake in shares of NantHealth during the second quarter valued at about $7,463,000. Finally, FMR LLC purchased a new stake in shares of NantHealth during the second quarter valued at about $11,250,000.
NantHealth, Inc, formerly Nant Health, LLC, is an evidence-based, personalized healthcare company. The Company’s systems-based approach to personalized healthcare applies diagnostics tailored to specific molecular profiles of patient tissues and integrates this molecular data in a clinical setting with real-time biometric signal and phenotypic data to track patient outcomes and deliver medicine.
Receive News & Ratings for NantHealth Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for NantHealth Inc and related companies with MarketBeat.com’s FREE daily email newsletter.